The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Open accessAbstract
OBJECTIVE: To correlate different methods of measuring rates of brain atrophy from serial MRI with corresponding clinical change in normal elderly subjects, patients with mild cognitive impairment (MCI), and patients with probable Alzheimer disease (AD). METHODS: One hundred sixty subjects were recruited from the Mayo Clinic Alzheimer's Disease Research Center and Alzheimer's Disease Patient Registry Studies. At baseline, 55 subjects were cognitively normal, 41 met criteria for MCI, and 64 met criteria for AD. Each subject underwent an MRI examination of the brain at the time of the baseline clinical assessment and then again at the time of a follow-up clinical assessment, 1 to 5 years later. The annualized changes in volume of four structures were measured from the serial MRI studies: hippocampus, entorhinal cortex, whole brain, and ventricle. Rates of change on several cognitive tests/rating scales were also assessed. Subjects who were classified as normal or MCI at baseline could either remain stable or convert to a lower-functioning group. AD subjects were dichotomized into slow vs fast progressors. RESULTS: All four atrophy rates were greater among normal subjects who converted to MCI or AD than among those who remained stable, greater among MCI subjects who converted to AD than among those who remained stable, and greater among fast than slow AD progressors. In general, atrophy on MRI was detected more consistently than decline on specific cognitive tests/rating scales. With one exception, no differences were found among the four MRI rate measures in the strength of the correlation with clinical deterioration at different stages of the disease. CONCLUSIONS: These data support the use of rates of change from serial MRI studies in addition to standard clinical/psychometric measures as surrogate markers of disease progression in AD. Estimated sample sizes required to power a therapeutic trial in MCI were an order of magnitude less for MRI than for change measures based on cognitive tests/rating scales.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Self-citationAccurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis
Smith, S. M., Zhang, Y., Jenkinson, M., Chen, J. M., Matthews, P. M., Federico, A., & Stefano, N. D. (2002) · NeuroImage · doi:10.1006/nimg.2002.1040 · Cited by 2,013
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Self-citationMedial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128
Self-citationRates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937
Self-citationAging, Memory, and Mild Cognitive Impairment
Petersen, R. C., Kokmen, E., Waring, S. C., Smith, G. E., Ivnik, R. J., & Tangelos, E. G. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004717 · Cited by 895
Self-citationCerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790
Cited by
Sorted by citations
Items 801–827 of 827
Association between late-life air pollution exposure and medial temporal lobe atrophy in older women
Wang, X., Salminen, L. E., Petkus, A. J., Driscoll, I. F., Millstein, J., Beavers, D. P., Espeland, M. A., Erus, G., Braskie, M. N., Thompson, P. M., et al. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.103378 · Cited by 1
Time’s up: Using data-driven phenotype-severity metrics not time to map progression in the dementiasPreprint
Smith, V., Schumacher, R., Ramanan, S., Bouzigues, A., Russell, L. L., Foster, P. H., Ferry‐Bolder, E., Swieten, J. C. V., Jiskoot, L. C., Seelaar, H., et al. (2026) · medRxiv · doi:10.64898/2026.01.28.26344700
Belzile, F., Chantal, S., Nolin, A., Nadeau, Y., Verret, L., & Hudon, C. (2026) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2026.10544
Automatic segmentation and shape analysis of human hippocampus in Alzheimer's disease
Shen, K. (2011) · theses.fr (ABES) · doi:10.70675/44a642b1z9128z4596z92f8z0f9767a16911
“, 2008, 2010) and ventricular enlargement (Jack et al., 2003; Thompson et al., 2004; Jack et al., 2004; Ridha et al., 2008) also indicate the progression of the neurodegeneration.”
Neuroimaging markers in clinical trials for pre-dementia stages of Alzheimer's disease
Cavedo, E. (2015) · theses.fr (ABES) · doi:10.70675/04f8d65dz4c15z4cebzbb7bz08189dec5d06
Taha, B. R., Benson, A., Arko, L., Harel, N., Sandoval-Garcia, C., Guillaume, D. J., & McGovern, R. A. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1639381
“Significant evidence exists supporting ventricular volume as a proxy for capturing AD progression/severity (99, 100).”
Hanbouch, L. (2017) · theses.fr (ABES) · doi:10.70675/c4d2c894zf69dz4ae4z9ab1zf4135d0efa12
Aderghal, K. (2021) · theses.fr (ABES) · doi:10.70675/b467dba8z5f34z4fafz8d11z5d8aa1f680d5 · Cited by 3
Lelong, E. (2021) · theses.fr (ABES) · doi:10.70675/7cda5a3ez022cz475az9b2bz977814a60663
Yang, X., Lyu, J., Wang, J., & Quan, Y. (2026) · BMC Neuroscience · doi:10.1186/s12868-026-01035-0
“When the volume of a given brain region is reduced, it is often difficult to determine whether this reflects a local change that simply accompanies whole-brain atrophy, or a specific spatial pattern beyond the global burden, within most current analytic frameworks .”
Knell, G., Meeker, K. L., Zhou, Z., Petersen, M. E., Hall, J. R., & O’Bryant, S. E. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261449514
Fan, L., Sun, Y., Liu, D., Robb, W. H., Pechman, K. R., Shashikumar, N., Vyas, Y., Landman, B. A., Hohman, T. J., & Jefferson, A. L. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71548
“…studies focusing on overall brain measures or the hippocampus alone reported progressively accelerated brain atrophy throughout the disease process, 52,53 other studies found that AD-specific cortical thinning and atrophy exhibited a sigmoidal pattern, with initial acceleration followed by…”
Hong, B., Tao, T., Li, Y., Gu, Z., Zhang, H., Chen, J., & Yue, L. (2026) · Diagnostics · doi:10.3390/diagnostics16121894
Amemiya, S., Takao, H., Matsumoto, S., Umeda‐Kameyama, Y., Niimi, Y., Kakumoto, T., Satake, W., Mitsui, J., Ogawa, S., & Abe, O. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261475336
“29 Furthermore, hippocampal atrophy predicts clinical decline more powerfully than whole-brain measures, 28 forecasting conversion to dementia even in cognitively normal individuals.”
Chen, X., O'Donnell, L., Sachdev, P. S., Wen, W., Numbers, K. T., Schwab, S., Zheng, P., Xie, Y., Liu, Z., & Brodaty, H. (2026) · Research Square · doi:10.21203/rs.3.rs-10564572/v1
Mehta, R. I., Jaisa-aad, M., Teixeira, C. V. L., Worhunsky, P. D., Malone, J. E., Ward, M., Keith, C. M., Phelps, H. E., Sharif, K., Pockl, S., et al. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70457
“36,37 Our study cohort consisted predominantly of individuals in the MCI stage with very early cognitive symptoms (mean MMSE was 27), differing substantially from many previously studied trial cohorts.”
Abdi, H., Sánchez‐Molina, D., Vilana, S. G., Azizi, S., Rahimi-Movaghar, V., & Haghighi, M. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150580
Early Prognosis of Alzheimer's Disease: Diagnostic Biomarker Review Article
Maghmomeh, A., Alkhoder, L., Turk, B., Habbal, A., & AL-Afandi, D. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00688
Computational anatomic methods as applied to aging and dementia
Thompson, P. M., & Apostolova, L. G. (2008)
Anatomia da Doença de Alzheimer: Correlação entre perfil Neuropsicológico e Imagem
Xavier, J. M. D. F. B. M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/q1s9-3z20
Resting-state functional magnetic resonance imaging in late-life depression and dementia
Kenny, E. R. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Basic Mechanisms: Cognitive Performance and Sleep
Wesensten, N. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.003
(2006) · PubMed · Cited by 269
Metadata
- Authors
- Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., Tangalos, E. G., & Petersen, R. C.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Neurology
- Published
- 2004-02-24
- Volume
- 62
- Issue
- 4
- Pages
- 591-600
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC2730165
- OpenAlex
- W2005133023
- Cited by
- 827
- References
- 41
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 21 · 2023: 25 · 2022: 20 · 2021: 36 · 2020: 27 · 2019: 38 · 2018: 36 · 2017: 37 · 2016: 33 · 2015: 39 · 2014: 41 · 2013: 48 · 2012: 38
- FWCI
- 28.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG-06786, AG 16574, U01AG006786, R01AG011378, AG-11378, U19AG010483, R37AG011378, P50AG016574)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, brain atrophy rate, serial MRI, hippocampal atrophy, entorhinal cortex atrophy, whole brain atrophy, ventriculomegaly, mild cognitive impairment, disease progression, surrogate markers, cognitive decline, trial size, MCI conversion
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Atrophy, Brain, Cognition Disorders, Female, Hippocampus, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Cohort Studies, Disease Progression, Entorhinal Cortex, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
